Mitsubishi UFJ Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$126K	Sell	41,048 -1,014	-2%	-$3.92K	﹤0.01%	1031
2025 Q4	$177K	Buy	42,062 +4,134	+11%	+$20.5K	﹤0.01%	1036
2025 Q3	$185K	Buy	37,928 +75	+0.2%	+$394	﹤0.01%	998
2025 Q2	$192K	Buy	37,853 +6,989	+23%	+$34.3K	﹤0.01%	981
2025 Q1	$163K	Buy	30,864 +2,587	+9%	+$18.9K	﹤0.01%	977
2024 Q4	$221K	Buy	28,277 +7,902	+39%	+$53.1K	﹤0.01%	976
2024 Q3	$134K	Sell	20,375 -1,917	-9%	-$13.7K	﹤0.01%	1002
2024 Q2	$167K	Sell	22,292 -2,622	-11%	-$22.9K	﹤0.01%	981
2024 Q1	$248K	Sell	24,914 -1,141	-4%	-$12.7K	﹤0.01%	937
2023 Q4	$252K	Sell	26,055 -6,947	-21%	-$49.5K	﹤0.01%	987
2023 Q3	$252K	Buy	33,002 +1,938	+6%	+$19.3K	﹤0.01%	1001
2023 Q2	$232K	Buy	31,064 +10,285	+49%	+$72K	﹤0.01%	1022
2023 Q1	$139K	Buy	20,779 +2,046	+11%	+$16.2K	﹤0.01%	1065
2022 Q4	$141K	Buy	+18,733	New	+$184K	﹤0.01%	1058
2022 Q2	–	Sell	-16,347	Closed	-$117K	–	1194
2022 Q1	$117K	Buy	16,347 +1,390	+9%	+$14.8K	﹤0.01%	1116
2021 Q4	$270K	Buy	+14,957	New	+$281K	﹤0.01%	1033